China Reinsurance (Group) Corporation (1508) released its main solvency and performance indicators for the third quarter of 2025, covering the Company at its own level and its subsidiaries (China Re P&C, China Re Life, and China Continent Insurance). According to the disclosed information, core and aggregated solvency adequacy ratios remained stable across all entities. At the Company’s own level, the aggregated solvency adequacy ratio was reported at 324%, accompanied by total assets of RMB100,502 million and net assets of RMB63,794 million.

China Re P&C recorded an aggregated solvency adequacy ratio of 224%, while China Re Life and China Continent Insurance reported 200% and 275% respectively. From January to September 2025, the Group’s consolidated insurance income reached RMB146,782 million, surpassing the RMB146,068 million figure for the same period in 2024. Over the same nine-month span, the Group’s consolidated net profit rose from RMB6,192 million in 2024 to RMB10,304 million in 2025, reflecting an ongoing focus on “expanding business scale, increasing underwriting profits and making prudent investment.”

Subsidiary financial highlights show China Re P&C and China Re Life contributed insurance income of RMB38,165 million and RMB49,525 million respectively, with China Continent Insurance achieving RMB42,169 million in insurance income. In terms of net profit for the January–September 2025 period, China Re P&C reported RMB2,252 million, China Re Life RMB2,949 million, while China Continent Insurance totaled RMB1,526 million. The Company expects continued balanced progress in underwriting and investment performance in alignment with its business strategy.